<SEC-DOCUMENT>0001104659-17-009184-index.html : 20170214 <SEC-HEADER>0001104659-17-009184.hdr.sgml : 20170214 <ACCEPTANCE-DATETIME>20170214141025 ACCESSION NUMBER: 0001104659-17-009184 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20170214 DATE AS OF CHANGE: 20170214 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Gemphire Therapeutics Inc. CENTRAL INDEX KEY: 0001638287 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 472389984 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-89598 FILM NUMBER: 17606888 BUSINESS ADDRESS: STREET 1: 17199 N. LAUREL PARK DRIVE STREET 2: SUITE 401 CITY: LIVONIA STATE: MI ZIP: 48152 BUSINESS PHONE: 248-980-6538 MAIL ADDRESS: STREET 1: 17199 N. LAUREL PARK DRIVE STREET 2: SUITE 401 CITY: LIVONIA STATE: MI ZIP: 48152 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Lowenschuss David CENTRAL INDEX KEY: 0001674050 FILING VALUES: FORM TYPE: SC 13G MAIL ADDRESS: STREET 1: 17199 N. LAUREL PARK DRIVE STREET 2: SUITE 401 CITY: LIVONIA STATE: MI ZIP: 48152 </SEC-HEADER> <DOCUMENT> <TYPE>SC 13G <SEQUENCE>1 <FILENAME>a17-4357_3sc13g.htm <DESCRIPTION>SC 13G <TEXT> Document 1 - file: a17-4357_3sc13g.htm
</DOCUMENT> </SEC-DOCUMENT>